author-photo

Juan A. Arnaiz

University of Barcelona

15

Papers

873

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study.

2016 Clinical Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (20)
Role of a research ethics committee in follow-up and publication of results

2011
Show All
- Source
- Cite
- Save
Citations (0)
Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patients

2007 AIDS
Show All
- Source
- Cite
- Save
Citations (29)
Health-related quality of life in HIV patients switching to twice-daily indinavir/ritonavir regimen or continuing with three-times-daily indinavir-based therapy.

2004 Antiviral Therapy
Show All
- Source
- Cite
- Save
Citations (7)
Role of a research ethics committee in follow-up and publication of results 1 1 Edited by Hans E. Gr

2003 American Journal of Ophthalmology
Show All
- Source
- Cite
- Save
Citations (0)
Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors

2003 Antiviral Therapy
Show All
- Source
- Cite
- Save
Citations (32)
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.

2003 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (282)
Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load.

2003 AIDS
Show All
- Source
- Cite
- Save
Citations (52)
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy

2001 AIDS
Show All
- Source
- Cite
- Save
Citations (340)